Lau Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $866K | Buy |
9,559
+6,251
| +189% | +$566K | 0.43% | 52 |
|
|
2019
Q3 | $287K | Hold |
3,308
| – | – | 0.15% | 82 |
|
|
2019
Q2 | $302K | Sell |
3,308
-384
| -10% | -$35.1K | 0.14% | 77 |
|
|
2019
Q1 | $318K | Hold |
3,692
| – | – | 0.16% | 74 |
|
|
2018
Q4 | $284K | Hold |
3,692
| – | – | 0.16% | 83 |
|
|
2018
Q3 | $285K | Sell |
3,692
-744
| -17% | -$57.4K | 0.16% | 79 |
|
|
2018
Q2 | $300K | Hold |
4,436
| – | – | 0.21% | 64 |
|
|
2018
Q1 | $321K | Hold |
4,436
| – | – | 0.25% | 63 |
|
|
2017
Q4 | $334K | Hold |
4,436
| – | – | 0.26% | 61 |
|
|
2017
Q3 | $341K | Hold |
4,436
| – | – | 0.26% | 61 |
|
|
2017
Q2 | $332K | Hold |
4,436
| – | – | 0.27% | 62 |
|
|
2017
Q1 | $295K | Hold |
4,436
| – | – | 0.26% | 67 |
|
|
2016
Q4 | $290K | Hold |
4,436
| – | – | 0.29% | 62 |
|
|
2016
Q3 | $314K | Hold |
4,436
| – | – | 0.32% | 63 |
|
|
2016
Q2 | $328K | Hold |
4,436
| – | – | 0.35% | 62 |
|
|
2016
Q1 | $288K | Hold |
4,436
| – | – | 0.3% | 62 |
|
|
2015
Q4 | $342K | Hold |
4,436
| – | – | 0.37% | 54 |
|
|
2015
Q3 | $365K | Hold |
4,436
| – | – | 0.43% | 50 |
|
|
2015
Q2 | $391K | Hold |
4,436
| – | – | 0.38% | 52 |
|
|
2015
Q1 | $392K | Sell |
4,436
-558
| -11% | -$49.3K | 0.37% | 51 |
|
|
2014
Q4 | $415K | Hold |
4,994
| – | – | 0.38% | 52 |
|
|
2014
Q3 | $421K | Hold |
4,994
| – | – | 0.39% | 48 |
|
|
2014
Q2 | $405K | Hold |
4,994
| – | – | 0.36% | 50 |
|
|
2014
Q1 | $380K | Hold |
4,994
| – | – | 0.34% | 52 |
|
|
2013
Q4 | $360K | Hold |
4,994
| – | – | 0.32% | 52 |
|
|
2013
Q3 | $343K | Hold |
4,994
| – | – | 0.29% | 48 |
|
|
2013
Q2 | $316K | Buy |
+4,994
| New | +$316K | 0.27% | 54 |
|